Richard S Bennett
Overview
Explore the profile of Richard S Bennett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maximova O, Anzick S, Sturdevant D, Bennett R, Faucette L, St Claire M, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012530.
PMID: 39841753
Viral infections of the central nervous system (CNS) are a major cause of morbidity largely due to lack of prevention and inadequate treatments. While mortality from viral CNS infections is...
2.
Normandin E, Triana S, Raju S, Lan T, Lagerborg K, Rudy M, et al.
Cell Genom
. 2024 Jan;
3(12):100440.
PMID: 38169842
Ebola virus (EBOV) causes Ebola virus disease (EVD), marked by severe hemorrhagic fever; however, the mechanisms underlying the disease remain unclear. To assess the molecular basis of EVD across time,...
3.
Liu D, Pahar B, Perry D, Xu H, Cooper T, Huzella L, et al.
Am J Pathol
. 2023 Sep;
193(12):2031-2046.
PMID: 37689386
The pathophysiology of long-recognized hematologic abnormalities in Ebolavirus (EBOV) disease (EVD) is unknown. From limited human sampling (of peripheral blood), it has been postulated that emergency hematopoiesis plays a role...
4.
Santus L, Sopena-Rios M, Garcia-Perez R, Lin A, Adams G, Barnes K, et al.
Nat Commun
. 2023 Jun;
14(1):3866.
PMID: 37391481
Long non-coding RNAs (lncRNAs) are involved in numerous biological processes and are pivotal mediators of the immune response, yet little is known about their properties at the single-cell level. Here,...
5.
Liu D, Pahar B, Cooper T, Perry D, Xu H, Huzella L, et al.
J Infect Dis
. 2023 Jun;
228(4):371-382.
PMID: 37279544
Background: Ebola virus (EBOV) disease (EVD) is one of the most severe and fatal viral hemorrhagic fevers and appears to mimic many clinical and laboratory manifestations of hemophagocytic lymphohistiocytosis syndrome...
6.
Tseng A, Carossino M, Gertje H, OConnell A, Gummuluru S, Kolachalama V, et al.
Vet Pathol
. 2023 May;
60(4):473-487.
PMID: 37170900
The liver is an early systemic target of Ebola virus (EBOV), but characterization beyond routine histopathology and viral antigen distribution is limited. We hypothesized Ebola virus disease (EVD) systemic proinflammatory...
7.
Wang Z, Bennett R, Roehler M, Guillon G, Fischl M, Donadi M, et al.
Viruses
. 2023 Feb;
15(2).
PMID: 36851550
The genus contains multiple species of viruses that are highly contagious and lethal, often causing severe hemorrhagic fever. To minimize the global threat from Ebola virus disease (EVD), sustainable, field-appropriate...
8.
Jiang S, Mukherjee N, Bennett R, Chen H, Logue J, Dighero-Kemp B, et al.
Front Immunol
. 2021 Dec;
12:729845.
PMID: 34938283
Non-human primate (NHP) animal models are an integral part of the drug research and development process. For some biothreat pathogens, animal model challenge studies may offer the only possibility to...
9.
Liu D, Cooper T, Perry D, Huzella L, Hischak A, Hart R, et al.
Am J Pathol
. 2021 Oct;
192(1):121-129.
PMID: 34626576
The pathogenesis of Ebola virus disease (EVD) is still incomplete, in spite of the availability of a nonhuman primate modelfor more than 4 decades. To further investigate EVD pathogenesis, a...
10.
Bennett R, Postnikova E, Liang J, Gross R, Mazur S, Dixit S, et al.
Viruses
. 2021 Jun;
13(5).
PMID: 34065987
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic expanded, it was clear that effective testing for the presence of neutralizing antibodies in the blood of convalescent patients would...